Over 10 mio. titler Fri fragt ved køb over 499,- Hurtig levering 30 dages retur

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2

- Diagnosis, Therapeutic Targets, and Molecular Mechanisms

Forfatter: info mangler
Bog
  • Format
  • Bog, hardback
  • Engelsk

Beskrivelse

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies. This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.

Læs hele beskrivelsen
Detaljer
  • SprogEngelsk
  • Sidetal398
  • Udgivelsesdato01-04-2022
  • ISBN139780323988070
  • Forlag Academic Press Inc
  • FormatHardback
Størrelse og vægt
  • Vægt1000 g
  • coffee cup img
    10 cm
    book img
    19,1 cm
    23,5 cm

    Findes i disse kategorier...

    Se andre, der handler om...

    Migration Insulin Resistance Diagnosis Ion channels Liver transplantation Mathematical models Liver Neoplasms Metabolism Liver Cirrhosis Risk factors Pathophysiology Phosphorylation Metastasis Inhibitors Drug Resistance Glucose Multidrug resistance Signaling Reactive Oxygen Species Sensitivity MicroRNA Precision Medicine Pathways Hepatocellular carcinoma (HCC) Hepatocellular Cancer Hippo Signaling pathways Steatosis Next Generation Sequencing, NGS Noncoding RNA Notch Biomarkers Gene Ontology Epithelial-mesenchymal transition Gene transcription Angiogenesis Radiofrequency Ablation Specificity RNA-Sequence ECM Sorafenib Heterogeneity HCC AFP Long noncoding RNAs EGFR EMT Signaling pathway Liver cancer Biomarker Cell signaling HER2 Hepatocellular Carcinoma Hepatocarcinogenesis MTOR MAP kinase Heat Shock Protein Perfusion-MRI Nuclear receptor Adenosine monophosphate kinase Antiangiogenic treatment AP-1 Bioinformatics analysis BCLC staging system Chemoresistance molecularly targeted agents Des-gamma-carboxyprothrombin Dickkopf-1 E2F Des-?-carboxyprothrombin Hepatitis B and C virus HIFs FOXM1 Glycocholate genetic profiling Golgi protein 73 HGF/MET Invasiveness Heteromeric complexes JAK/STAT Enzymes and pathways Malignant liver cancer NF-?B osteopontin PIVKA-II nodal Perfusion CT Phosphatidylinositol proteoglycan PI3K-AKT Proliferative signaling Potential markers Rho-A Prognostic Factors Specificity protein 1 Serine threonine kinase 11 Liver kinase B1 Protein induced by vitamin K deficiency Molecular heterogeneity Phenylalanyl-tryptophan
    Machine Name: SAXO080